Park S, Hall M
Exp Mol Med. 2025; .
PMID: 40025169
DOI: 10.1038/s12276-025-01415-2.
Pena F, Martin-Cano F, Becerro-Rey L, da Silva-Alvarez E, Gaitskell-Phillips G, Aparicio I
Antioxidants (Basel). 2025; 14(2).
PMID: 40002411
PMC: 11852293.
DOI: 10.3390/antiox14020225.
He K, Tao F, Lu Y, Fang M, Huang H, Zhou Y
Int J Med Sci. 2025; 22(4):790-805.
PMID: 39991762
PMC: 11843137.
DOI: 10.7150/ijms.105553.
Zhang Y, Zhao J, Zhou J, Jiang Z, Cheng K, Lei C
J Transl Med. 2025; 23(1):200.
PMID: 39966959
PMC: 11837638.
DOI: 10.1186/s12967-025-06212-z.
Som R, Fink B, Rauckhorst A, Taylor E, Sivitz W
J Bioenerg Biomembr. 2025; .
PMID: 39954225
DOI: 10.1007/s10863-025-10053-2.
O-GlcNAcylation attenuates ischemia-reperfusion-induced pulmonary epithelial cell ferroptosis via the Nrf2/G6PDH pathway.
Yang L, Tang H, Wang J, Xu D, Xuan R, Xie S
BMC Biol. 2025; 23(1):32.
PMID: 39901237
PMC: 11792224.
DOI: 10.1186/s12915-025-02126-w.
Glucose-6-phosphate dehydrogenase regulates mitophagy by maintaining PINK1 stability.
Cho Y, Tan H, Yang J, Kuah B, Lim N, Fu N
Life Metab. 2025; 4(1):loae040.
PMID: 39872984
PMC: 11749863.
DOI: 10.1093/lifemeta/loae040.
CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis.
Yao H, Ge J, Chen J, Tang X, Li C, Hu X
J Exp Clin Cancer Res. 2025; 44(1):26.
PMID: 39865281
PMC: 11771065.
DOI: 10.1186/s13046-025-03295-w.
A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis.
Khayer N, Shabani S, Jalessi M, Joghataei M, Mahjoubi F
Sci Rep. 2025; 15(1):3322.
PMID: 39865116
PMC: 11770085.
DOI: 10.1038/s41598-024-82668-1.
Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival.
Komza M, Khatun J, Gelles J, Trotta A, Abraham-Enachescu I, Henao J
Cell Commun Signal. 2025; 23(1):47.
PMID: 39863913
PMC: 11762851.
DOI: 10.1186/s12964-025-02044-y.
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.
Qiao J, Yu Z, Zhou H, Wang W, Wu H, Ye J
Int J Mol Sci. 2025; 26(2).
PMID: 39859324
PMC: 11765532.
DOI: 10.3390/ijms26020610.
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.
Zuo Q, Kang Y
Adv Exp Med Biol. 2025; 1464():347-370.
PMID: 39821033
DOI: 10.1007/978-3-031-70875-6_17.
Unraveling the potential mechanism and prognostic value of pentose phosphate pathway in hepatocellular carcinoma: a comprehensive analysis integrating bulk transcriptomics and single-cell sequencing data.
Li B, Zeng T, Chen C, Wu Y, Huang S, Deng J
Funct Integr Genomics. 2025; 25(1):11.
PMID: 39798003
DOI: 10.1007/s10142-024-01521-w.
Exploring the Metabolic Impact of FLASH Radiotherapy.
Geirnaert F, Kerkhove L, Montay-Gruel P, Gevaert T, Dufait I, De Ridder M
Cancers (Basel). 2025; 17(1.
PMID: 39796760
PMC: 11720285.
DOI: 10.3390/cancers17010133.
The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches.
Abdullah A, Kumbrink J, Liokatis P, Mock A, Abdullah A, Dewenter I
Cancers (Basel). 2025; 17(1.
PMID: 39796677
PMC: 11718909.
DOI: 10.3390/cancers17010048.
SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway.
Gong Y, Gao D, Shi Y, Fan G, Yu X, Yang E
Commun Biol. 2025; 8(1):36.
PMID: 39794543
PMC: 11724026.
DOI: 10.1038/s42003-024-07284-1.
Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis.
Kaur R, Gupta S, Kulshrestha S, Khandelwal V, Pandey S, Kumar A
Cells. 2025; 14(1.
PMID: 39791706
PMC: 11720085.
DOI: 10.3390/cells14010005.
Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation.
Zheng Z, Xiao P, Kuang J, Wang Z, Wang X, Huang D
J Cancer. 2025; 16(3):821-834.
PMID: 39781339
PMC: 11705062.
DOI: 10.7150/jca.105849.
Disulfidptosis and Its Hub Gene Slc3a2 Involved in Ulcerative Colitis Pathogenesis, Disease Progression, and Patient Responses to Biologic Therapies.
Yang Q, Guo J, Zhang K, Li S, Xia W, Wang D
Int J Mol Sci. 2025; 25(24.
PMID: 39769269
PMC: 11728241.
DOI: 10.3390/ijms252413506.
Tumor Metabolic Reprogramming and Ferroptosis: The Impact of Glucose, Protein, and Lipid Metabolism.
Zhu K, Cai Y, Lan L, Luo N
Int J Mol Sci. 2025; 25(24.
PMID: 39769177
PMC: 11676715.
DOI: 10.3390/ijms252413413.